MOVE Stock Overview
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Medacta Group SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF115.40 |
| 52 Week High | CHF123.40 |
| 52 Week Low | CHF76.70 |
| Beta | 1.12 |
| 1 Month Change | -4.79% |
| 3 Month Change | 13.14% |
| 1 Year Change | 7.85% |
| 3 Year Change | 41.60% |
| 5 Year Change | n/a |
| Change since IPO | 20.08% |
Recent News & Updates
At CHF117, Is It Time To Put Medacta Group SA (VTX:MOVE) On Your Watch List?
Apr 28
Is Medacta Group (VTX:MOVE) A Risky Investment?
Apr 08Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?
Dec 25Recent updates
At CHF117, Is It Time To Put Medacta Group SA (VTX:MOVE) On Your Watch List?
Apr 28Is Medacta Group (VTX:MOVE) A Risky Investment?
Apr 08Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?
Dec 25Capital Allocation Trends At Medacta Group (VTX:MOVE) Aren't Ideal
Dec 09Does Medacta Group (VTX:MOVE) Have A Healthy Balance Sheet?
Nov 09Why Medacta Group SA (VTX:MOVE) Could Be Worth Watching
Sep 16The Returns On Capital At Medacta Group (VTX:MOVE) Don't Inspire Confidence
Aug 20Here's Why Medacta Group (VTX:MOVE) Has Caught The Eye Of Investors
Jul 02Should You Think About Buying Medacta Group SA (VTX:MOVE) Now?
May 28Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return
May 12These 4 Measures Indicate That Medacta Group (VTX:MOVE) Is Using Debt Reasonably Well
Mar 31Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?
Mar 17Capital Investments At Medacta Group (VTX:MOVE) Point To A Promising Future
Feb 07Should You Investigate Medacta Group SA (VTX:MOVE) At CHF133?
Dec 10Medacta Group (VTX:MOVE) Knows How To Allocate Capital
Nov 05Here's Why Medacta Group (VTX:MOVE) Can Manage Its Debt Responsibly
Sep 30Is It Too Late To Consider Buying Medacta Group SA (VTX:MOVE)?
Aug 26Medacta Group (VTX:MOVE) May Have Issues Allocating Its Capital
Jul 20Should You Investigate Medacta Group SA (VTX:MOVE) At CHF119?
May 19We Think Medacta Group (VTX:MOVE) Can Stay On Top Of Its Debt
Apr 05What You Need To Know About Medacta Group SA's (VTX:MOVE) Investor Composition
Mar 02Is Medacta Group SA's (VTX:MOVE) 7.6% ROE Better Than Average?
Feb 02The Medacta Group (VTX:MOVE) Share Price Has Gained 24% And Shareholders Are Hoping For More
Jan 12
Returns On Capital At Medacta Group (VTX:MOVE) Paint An Interesting Picture
Dec 21Should You Use Medacta Group's (VTX:MOVE) Statutory Earnings To Analyse It?
Dec 03Shareholder Returns
| MOVE | CH Medical Equipment | CH Market | |
|---|---|---|---|
| 7D | 4.9% | 0.9% | -0.1% |
| 1Y | 7.9% | -4.0% | -2.6% |
Return vs Industry: MOVE exceeded the Swiss Medical Equipment industry which returned -3.1% over the past year.
Return vs Market: MOVE exceeded the Swiss Market which returned -2.6% over the past year.
Price Volatility
| MOVE volatility | |
|---|---|
| MOVE Average Weekly Movement | 4.2% |
| Medical Equipment Industry Average Movement | 4.3% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in CH Market | 7.2% |
| 10% least volatile stocks in CH Market | 2.1% |
Stable Share Price: MOVE is not significantly more volatile than the rest of Swiss stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: MOVE's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1958 | 1,537 | Francesco Siccardi | https://www.medacta.com |
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized 3D planning tools for use in hip, knee, shoulder, sports medicine, and spine procedures. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
Medacta Group SA Fundamentals Summary
| MOVE fundamental statistics | |
|---|---|
| Market Cap | CHF2.30b |
| Earnings (TTM) | CHF45.14m |
| Revenue (TTM) | CHF426.68m |
51.0x
P/E Ratio5.4x
P/S RatioIs MOVE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MOVE income statement (TTM) | |
|---|---|
| Revenue | €437.12m |
| Cost of Revenue | €131.87m |
| Gross Profit | €305.26m |
| Other Expenses | €259.01m |
| Earnings | €46.25m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
Jul 28, 2023
| Earnings per share (EPS) | 2.32 |
| Gross Margin | 69.83% |
| Net Profit Margin | 10.58% |
| Debt/Equity Ratio | 52.7% |
How did MOVE perform over the long term?
See historical performance and comparison